<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <title>Compliance with Ethical Standards</title>
 <notes notes-type="funding">
  <title>Funding</title>
  <p>No funding has been received for the preparation of this article.</p>
 </notes>
 <notes notes-type="COI-statement">
  <title>Conflict of interest</title>
  <p id="Par22">Tiago Torres has received consultancy and/or speaker’s honoraria from and/or participated in clinical trials sponsored by AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Janssen, Biocad, LEO Pharma, Eli Lilly, MSD, Novartis, Pfizer, Samsung-Bioepis, Sanofi-Genzyme, and Sandoz. Luis Puig has received consultancy and/or speaker’s honoraria from and/or participated in clinical trials sponsored by AbbVie, Almirall, Amgen, Baxalta, Biogen, Boehringer Ingelheim, Celgene, Gebro, Janssen, LEO Pharma, Eli Lilly and Company, Merck-Serono, MSD, Mylan, Novartis, Pfizer, Regeneron, Roche, Sandoz, Samsung-Bioepis, Sanofi, and UCB.</p>
 </notes>
</notes>
